Through a different mechanism, long-term chemotherapy may induce chemoresistance by upregulation of miR-92a-3p, and subsequent downregulation of ERCC2 and XRCC1 expression in colon cancer, promoting hypermutability and tumor heterogeneity. Here, ERCC2 is linked to neoplasm.